Clinical Trials in Tennessee

Showing 5901-5920 of 15,329 trials

Determinants of Alpha-aminoadipic Acid (2-AAA) and Relationship to Diabetes: Study 2

NCT04417218

This study aims to assess the effect of controlled dietary lysine intake on plasma and urine α-aminoadipic acid (2-AAA).

Healthy

Vanderbilt University Medical Center67 participantsStarted Aug 2020

Nashville, Tennessee, United States

RECRUITING29 miles

A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma

NCT03941379

The purpose of this observational research study is to follow participants who have been treated with either bel-sar or received alternate treatment (sham, standard of care therapy, etc.) while participating in a previous Aura Biosciences clinical research study to assess the long-term safety and effectiveness in these subjects. This study will collect information from procedures conducted as part of routine follow-up eye care and cancer care. Additionally, the registry will collect all adverse events, information about pregnancy and symptomatic overdose.

Choroidal MelanomaIndeterminate Lesions of Eye

Aura Biosciences500 participantsStarted Mar 2019

Tucson, Arizona, United States • Los Angeles, California, United States • Palo Alto, California, United States +13 more locations

Determinants of Alpha-aminoadipic Acid (2-AAA) and Relationship to Diabetes: Study 2

A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma

Find Trials by Condition in Tennessee

Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer

A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms

Derazantinib in Subjects With FGFR2 Gene Fusion-, Mutation- or Amplification- Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma

Study to Test the Efficacy and Safety of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adults With Drug-resistant Epilepsy

Shockwave Medical Peripheral Lithoplasty System Study for PAD (Disrupt PAD III)

A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Moderate-to-Severe Atopic Hand and Foot Dermatitis (Liberty-AD-HAFT)

A Long-Term Safety and Efficacy Study of Lorecivivint in Subjects With Osteoarthritis of the Knee

Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult and Pediatric Patients With COVID-19

Trial to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis

Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular Melanoma

Trial of mFOLFOX6 + Trastuzumab + Avelumab in Gastric and Esophageal Adenocarcinomas

Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone

Sinusoidal Obstruction Syndrome for Stem Cell Transplant Patients Biomarker Study

Medibio DDA Confirmatory Performance Study

A Study to Determine the Efficacy and Safety of Luspatercept in Adults With Non Transfusion Dependent Beta (β)-Thalassemia

Study of the CD40 Agonistic Monoclonal Antibody APX005M

A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours

A Clinical Study Evaluating Nivolumab-containing Treatments in Patients With Advanced Non-small Cell Lung Cancer After Failing Previous PD-1/(L)1 Therapy and Chemotherapy